Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT1 | P35610 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | LTB4R | Q15722 | 11/20 | 0.46 |
| ▸ | ATP4A | P20648 | 2/20 | 0.44 |
| ▸ | ATP4B | P51164 | 2/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6001936 | 0.85 | HTR7 (0.45) | SOAT1CYP1A2CYP2D6CYP19A1CYP2C9 | |
| SCHEMBL8583652 | 0.84 | SOAT1 (0.51) | SOAT1LTA4HTLR8 | |
| SCHEMBL2300904 | 0.83 | RAB9A (0.57) | MEN1RAB9AKMT2A | |
| SCHEMBL11204150 | 0.83 | RAB9A (0.46) | MEN1RAB9AKMT2ALTB4R | |
| SCHEMBL7110386 | 0.81 | LTB4R (0.68) | LTB4R | |
| SCHEMBL2520179 | 0.80 | LTA4H (0.50) | SOAT1MEN1KMT2ACYP1A2CYP2D6 | |
| SCHEMBL11204040 | 0.80 | LTB4R (0.71) | LTB4R | |
| SCHEMBL24306014 | 0.80 | SOAT1 (0.48) | SOAT1LTA4HTLR8 | |
| SCHEMBL8987192 | 0.79 | LTB4R (0.71) | LTB4R | |
| SCHEMBL8987271 | 0.79 | LTB4R (0.71) | LTB4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1284968-B1 | METHOD OF COMBATING UNDESIRED PLANT GROWTH ON CEREALS | BASF AG (DE) | 2007-03-14 | — | — | EP | disclosed |
| US-7008905-B2 | Method of combating undesired plant growth on cereals | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-07 | — | — | US | disclosed |
| EP-1284968-A1 | METHOD OF COMBATING UNDESIRED PLANT GROWTH ON CEREALS | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-26 | — | — | EP | disclosed |
| US-20020049141-A1 | Herbicides such as 4-(3-Trifluoromethylphenoxy)-2-(4-trifluoromethyl-phenyl)-pyri midine or 4-(2-chloropyrid-4-yloxy) -2-(4-trifluoromethylphenyl)-pyrimidine | BASF AKTIENGESELLSCHAFT (DE) | 2002-04-25 | — | — | US | disclosed |
| WO-2001090080-A1 | METHOD OF COMBATING UNDESIRED PLANT GROWTH ON CEREALS | BASF AKTIENGESELLSCHAFT (DE) | 2001-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020049141-A1 | Herbicides such as 4-(3-Trifluoromethylphenoxy)-2-(4-trifluoromethyl-phenyl)-pyri midine or 4-(2-chloropyrid-4-yloxy) -2-(4-trifluoromethylphenyl)-pyrimidine | CYP2W1, MTX2, MTX1 | SOAT1 3478/4885MEN1 3456/4885RAB9A 2810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.